Testing a bacteria pill to prevent diarrhea from chemotherapy
Part of Cancer, Digestive system clinical trials.
This trial tests if a pill made from a harmless bacteria can prevent diarrhea caused by certain chemotherapy treatments. It is for people with advanced colorectal cancer or breast cancer who are about to start specific treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced colorectal cancer about to start FOLFIRI chemotherapy, or breast cancer about to start neratinib.
- You are 18 or older.
- Your overall health is good enough for daily activities (ECOG score 0-1).
- You do not have conditions like inflammatory bowel disease or chronic diarrhea.
- You are not taking antibiotics or certain other medications during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special probiotic supplement (good bacteria) can reduce belly discomfort caused by abemaciclib, a hormone therapy drug for early breast cancer. You would take the supplement alongside your cancer treatment to see if it helps with stomach side effects.
This trial tests whether taking probiotics can help prevent diarrhea caused by the breast cancer drug neratinib. If you are a woman with HER2-positive breast cancer and are about to start neratinib, this study may help manage a common side effect.
This trial looks at how changes in the gut (microbiome) relate to diarrhea that can happen after starting anti-cancer therapy. It may help doctors better predict and manage treatment-related diarrhea.
This study tests whether a specially engineered yeast (taken as a pill) can safely help prevent Clostridioides difficile infection—a serious gut infection that can develop after antibiotics. Part A enrolls healthy volunteers; Part B enrolls people at higher risk (those with prior C. difficile, recent hospitalization, or recent antibiotics).
This trial tests an investigational oral medication (SER-155) for people whose diarrhea is caused by immunotherapy. It aims to calm the gut and reduce symptoms without needing stronger drugs.
This trial tests whether taking a probiotic called Clostridium butyricum can reduce side effects during chemotherapy after colorectal cancer surgery. It's for people who have had their tumor removed and are about to start adjuvant treatment.
Hear when a new Chemotherapy-induced Diarrhea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.